Add like
Add dislike
Add to saved papers

Radioulnar heterotopic ossification after distal biceps tendon repair: results following surgical resection.

PURPOSE: The purpose of this study is to evaluate the clinical outcome of patients who had excision of a radioulnar heterotopic ossification (HO) as a complication of a distal biceps tendon repair. The hypothesis is that there are no measurable clinical losses that persist after excision.

METHODS: Eight consecutive patients were identified between 1996 and 2005. All were treated with HO excision using a standard surgical technique and rehabilitation protocol. These individuals were studied and compared to a matched cohort of 8 patients who had a distal biceps tendon repair with a similar surgical technique that was uncomplicated. All study patients were evaluated at a minimum 1-year follow-up with physical examination, isokinetic dynamometry, and outcome measures. Comparisons were made both between groups as well as side-to-side within groups.

RESULTS: At follow-up examination, the mean arc of forearm rotation in the HO group measured 151 degrees. The mean arc of forearm rotation in the control group measured 165 degrees. With the numbers available, no measurable differences in arc of motion were identified between groups (p > .05). When compared to the normal, uninvolved side, patients who developed HO lost an average of 9 degrees of forearm pronation (p < .01). No differences were identified between the HO and control groups with respect to isokinetic torque, endurance strength, or Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire (American Academy of Orthopaedic Surgeons, Rosemont, IL) scores (p > .05).

CONCLUSIONS: When patients develop motion-limiting HO after distal biceps tendon repair, surgical resection can lead to a functional recovery of elbow and forearm motion. Biceps strength can be maintained with no measurable differences in clinical outcome when compared to individuals who do not suffer this complication following distal biceps repair.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app